Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves 1st Non-Opioid Pain Drug in 20 Years
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
FDA upgrades recall of Lay's potato chips
Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?
The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.
Lay's potato chips recalled over life-threatening risk as FDA issues warning
Lay recall on Lay's Classic Potato Chips across Oregon and Washington was updated to a Class 1 recall by the FDA on Thursday.
2d
on MSN
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
22h
US FDA Identifies Cybersecurity Risks in Certain Patient Monitors
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...
Hosted on MSN
59m
CMRX Stock Skyrockets in 3 Months: Here's What You Should Know
Shares of Chimerix CMRX have skyrocketed 323.7% in the past three months following the company’s submission of a new drug ...
Healio
1h
Top in allergy/asthma: ‘Psychosocial burden’ of food allergy; peanut allergy patch
Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...
WAAY-TV
1h
Best practices to avoid counterfeit Botox and other injectables
"Faux-tox" or fake botox is popping up across the country. With the allure of younger looking skin at discounted prices and through third parties, professionals are sending a warning about ...
clickondetroit.com
1h
Child killed in hyperbaric chamber explosion at Oakland County healthcare facility
A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...
Opinion
21h
Opinion
Do food warning labels actually work? Answering your questions.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
21h
Walmart's Broccoli Recall Now Classified As Potentially Deadly, According To The FDA
In early January it was revealed that Walmart's washed and ready-to-eat 12 oz. Marketside Broccoli Florets were voluntarily ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Popular topics
# FDA
Related topics
Food and Drug Administration
Trump
Washington
Journavx
United States
Feedback